Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

205
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
205
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

199
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
199
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

15
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
15
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

497
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
497
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

582
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
582
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

223
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
223

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

International Outcomes of the Boston Type I Keratoprosthesis in Stevens-Johnson Syndrome.

Cornea·2015
Same author

Insights triggered by textual micro-counseling dialogues of restructuring orientation in experts and students.

PsyCh journal·2015
Same author

Water-enhanced Removal of Ciprofloxacin from Water by Porous Graphene Hydrogel.

Scientific reports·2015
Same author

Development of Small-molecule HIV Entry Inhibitors Specifically Targeting gp120 or gp41.

Current topics in medicinal chemistry·2015
Same author

Synthesis and biological evaluation of ring A and/or C expansion and opening echinocystic acid derivatives for anti-HCV entry inhibitors.

European journal of medicinal chemistry·2015
Same author

Visual Acuity, Contrast Sensitivity and Color Vision Three Years After Iodine-125 Brachytherapy for Choroidal and Ciliary Body Melanoma.

The open ophthalmology journal·2015
Same journal

Short-term responsiveness of DNA methylation-based aging biomarkers to a multimodal intervention comprising exercise and dietary guidance involving daily consumption of yogurt containing <i>Bifidobacterium longum</i> BB536: an exploratory randomized controlled trial.

Aging·2026
Same journal

Hormonal dimorphism in sarcopenia disease.

Aging·2026
Same journal

The multifaceted inducers of cellular senescence.

Aging·2026
Same journal

Life expectancy and causes of death in classical laminopathic progeroid syndromes: systematic review with individual-patient data synthesis.

Aging·2026
Same journal

Age-related dysfunctions of the neuroendocrine axes in nonhuman primates with depression-like and anxious behavior.

Aging·2026
Same journal

The love and hate relationship between cellular senescence and stemness.

Aging·2026
See all related articles

Related Experiment Video

Updated: Jul 27, 2025

Orienteering as a Tool for Cognitive Research: An Implementation Guide
07:13

Orienteering as a Tool for Cognitive Research: An Implementation Guide

Published on: November 29, 2024

837

Isoorientin ameliorates H

Tiehan Cui1,2, Yun Lan3, Yuying Lu3

  • 1Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Nanchang University, Nanchang 330006, China.

Aging
|June 5, 2023
PubMed
Summary
This summary is machine-generated.

Isoorientin (ISO) protects chondrocytes from oxidative stress, a key factor in osteoarthritis. This natural compound reduces apoptosis and enhances cellular function, offering potential for OA treatment.

Keywords:
RNA-seqapoptosisbioinformaticsisoorientinoxidative stress

More Related Videos

Screening and Isolation of C-Glycoside-Cleaving Intestinal Bacteria
06:38

Screening and Isolation of C-Glycoside-Cleaving Intestinal Bacteria

Published on: February 28, 2025

402
Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents
09:28

Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents

Published on: September 16, 2020

8.6K

Related Experiment Videos

Last Updated: Jul 27, 2025

Orienteering as a Tool for Cognitive Research: An Implementation Guide
07:13

Orienteering as a Tool for Cognitive Research: An Implementation Guide

Published on: November 29, 2024

837
Screening and Isolation of C-Glycoside-Cleaving Intestinal Bacteria
06:38

Screening and Isolation of C-Glycoside-Cleaving Intestinal Bacteria

Published on: February 28, 2025

402
Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents
09:28

Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents

Published on: September 16, 2020

8.6K

Area of Science:

  • Biochemistry
  • Cell Biology
  • Pharmacology

Background:

  • Osteoarthritis (OA) is a degenerative joint disease with no effective treatments.
  • Isoorientin (ISO), a plant extract with antioxidant properties, shows potential for OA therapy.
  • Research on ISO's protective mechanisms in OA models is limited.

Purpose of the Study:

  • To investigate the protective effects of ISO on H2O2-induced chondrocytes, an in vitro OA model.
  • To elucidate the molecular mechanisms underlying ISO's action.
  • To establish a theoretical basis for ISO's use in OA treatment.

Main Methods:

  • RNA sequencing (RNA-seq) and bioinformatics analysis.
  • Cellular assays measuring apoptosis, mitochondrial membrane potential (MMP), and reactive oxygen species (ROS).
  • Biochemical analysis of antioxidant enzymes (SOD, HO-1, NQO-1) and lipid peroxidation (MDA).

Main Results:

  • ISO significantly enhanced chondrocyte activity against H2O2-induced damage.
  • ISO reduced apoptosis and restored MMP by inhibiting MAPK signaling.
  • ISO increased antioxidant enzyme levels (SOD, HO-1, NQO-1), decreased MDA, and inhibited ROS via Nrf2 and PI3K/Akt pathways.

Conclusions:

  • ISO demonstrates significant protective effects against oxidative stress and apoptosis in chondrocytes.
  • ISO's mechanism involves modulating MAPK, Nrf2, and PI3K/Akt signaling pathways.
  • ISO shows promise as a therapeutic agent for osteoarthritis, warranting further investigation.